I agree totally although to be fair to the pharma industry they have not had any thing that looked like being a cure until very recently. What Gilead is doing is very encouraging and I think has a reasonable chance of working based on the SIV monkey data.
BIT has no data at all that BIT225 will aid in a cure for HIV. I know they have been talking it up that it might be part of one, but a 12 week trial in 18 people is not going to provide you with the data to support a cure. Gilead trial in the same area is in 80 people run over more than 3 years and this is only a phase 2 trial. The chances of BIT225 being part of any cure are remote IMO.
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-567
-
- There are more pages in this discussion • 472 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $7.664K | 403.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1202498 | 5 |
View Market Depth
| Last trade - 13.42pm 27/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |